Is it necessary to take lenvatinib in the middle and late stages of liver cancer? Pay attention to these matters when taking liver cancer medication

Lenvatinib generally refers to lenvatinib mesylate capsules. There is no need for patients in the middle and late stages of liver cancer to take lenvatinib mesylate capsules.

Lenvatinib Mesylate Capsules are anti-tumor drugs suitable for patients with unresectable hepatocellular carcinoma who have not received systemic treatment before. When patients reach the middle and late stages of liver cancer, liver function will be severely damaged, so there is no need to take Lenvatinib Mesylate Capsules. Because patients in the middle and late stages have a low tolerance to Lenvatinib Mesylate Capsules, they are more likely to have adverse drug reactions, which is not conducive to disease recovery.